The involvement of miRNAs throughout the progression of ALD and MASLD is comparatively examined, with particular emphasis on their roles in lipid metabolic dysregulation, mitochondrial and oxidative stress, autophagic dysfunction, immune activation, hepatocyte death, and hepatic-stellate-cell-associated fibrogenesis.
Minkyoung Gu, Chaebin Park, S. Kim et al.· Pharmaceutics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.